Revista Colombiana de Endocrinología, Diabetes y Metabolismo
Clinical and sociodemographic characteristics of patients with acute descompesation of type 2 diabetes in Hospital San José Bogotá Colombia (2010-2013)
PDF (Español (España))
HTML (Español (España))

Keywords

diabetes
decompensations
ketoacidosis
hypoglycemia
hyperosmolar

How to Cite

Rivera, M. C., & Tovar, H. (2018). Clinical and sociodemographic characteristics of patients with acute descompesation of type 2 diabetes in Hospital San José Bogotá Colombia (2010-2013). Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 5(3), 6–10. https://doi.org/10.53853/encr.5.3.428

Abstract

Introduction: Diabetes acute decompensations appear frequently. The most common presentation is CAD and hypoglicemia with roughly 145.000 cases a year. Hyperosmolar state (HOS) presents itself in less than 1% cases. These demand an appropriate and timely recognition and treatment.
Mortality attributable to CAD is 2% in general hospitals and 5% in specialized hospitals. Mortality in HOS is larger, between 15%-70%. This can be attributed to the type of population (advanced age) and to its comorbilities. Mortality due to hypoglicemia is around 20% in insulinized patients vs. 4.5% in non insulinized patients. In Colombia, very little is known about the behaviour of acute decompensations in our patients.
Objective: To describe demographic and clinical characteristics of patients suffering from Diabetes Mellitus 2 who have been admitted with acute decompensations to the internal medicine service in Hospital San José between October 2010 and August 2013.
Methods: Descriptive study which monitored a group of patients admitted to Hospital San José with Diabetes Mellitus type 2 and acute decompensations, recruited between October 2010 and August 2013.
Results: From a total of 470 patients, 45 presented cetoacidosis (9.5%), hyperosmolar state (4%) and hypoglicemia (9.5%). 76% had no decompensation when admitted. Time of evolution of the sickness was 9.7 years for cetoacidosis and for HOS and hypoglicemia approximately 13 years. Only 57% had access to self monitoring.
Women present decompensation more often: 48.9% do in cetoacidosis, 52.6% in hyperosmolar state, 64% in hypoglicemia. The most common reason for admittance is miscelaneous 39.4% followed by infections ( 35%). Most were out of metabolic control hba1c > 9%. 62% cetoacidosis, 68% hyperosmolar state, 33% hypoglicemia. About chronic complications, they were mostly microvascular especially in the hypoglicemic group. Mortality was more present in the CAD 6.6%, followed by hypoglicemia 4.4%. 30% had access to a glucometer for self monitoring. About 15% had suspended treatment for non adherence or non access to health.
Conclusion: The implementation of optimal programs based in a better metabolic control and individual treatment according to each case, the patient’s level of education, self monitoring and a multidisciplinary team can all serve to diminish the presence of acute decompensations. Mortality, when presented, lowers its levels if the cause of precipitation is timely and correctly managed.

https://doi.org/10.53853/encr.5.3.428
PDF (Español (España))
HTML (Español (España))

References

1. Página de la Organización Mundial de la Salud. Programas y proyectos > Centro de prensa > Notas descriptivas. Nota descriptiva No 312/ Noviembre de 2009 http://www.who.int/mediacentre/factsheets/fs312/es/index.html
2. Piniés J.A. Complicaciones agudas y crónicas, un riesgo que debe ser evitado. Rev. Esp Econom Salud 2008;7(2):64-67 descripcion adicional sobre la pagina en IDF http://www.Diabetesatlas.org/es/content/morbilidad-y-mortalidad y en http://www.idf.org/diabetesatlas/regional-overview.
3. Diaz-Apodaca BA, Ebrahim S, McCormack V, de Cosio FG, Ruiz-Holguin R. Prevalence of type 2 diabetes and impaired fasting glucose: cross-sectional study of multiethnic adult population at the United States-Mexico border. Rev Panam Salud Publica 2010 Sep;28(3):174-81.
4. Schargrodsky H, Hernandez-Hernandez R, Champagne BM, Silva H, Vinueza R, Silva Aycaguer LC, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008 Jan;121(1):58-65.
5. Aschner P. Síndrome Metabólico en una Poblaciòn Rural y una Poblaciòn Urbana de la Región Andina Colombiana. Revista Med - Universidad Militar Nueva Granada 2007 Jul 1;15(002):154-62.
6. Alayòn A, Alverar C. Prevalencia de desórdenes del metabolismo de los glúcidos y perfil del diabético en Cartagena de Indias (Colombia), 2005. Salud Uninorte Barraquilla (Colombia) 2011;22(1):20-8.
7. Villegas, A. El control de la diabetes mellitus y sus complicaciones en Medellín, Colombia, 2001-2003. Rev Panam Salud Publica [online]. 2006, 20; (6):393-402.
8. Guillermo Umpierrez, Mary Korytkowski Diabetic emergencies — keto- acidosis, hyperglycaemic hyperosmolar state and hypoglycaemia, Nat Rev Endocrinol. 2016.
9. Agency for Healthcare Research and Quality. Databases and related tools from the healthcare cost and utilization Project (HCUP) [article online]. National Center for Health Statistics, Centers for Disease Control. Available from www.hcup-us.ahrq.gov/reports/statbriefs. Accessed 24 January 2009.
10. Kitabchi, A. E., Umpierrez, G. E., Miles, J. M. & Fisher, J. N. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32, 1335-1343 (2009).
11. Ronald VN. Hyperglycemic crisis. The Journal of Emergency Medicine. 2103 Vol. 45, No. 5, pp. 797-805-9.
12. Ministerio de Salud - Dirección General de Promoción y Prevención, Guía de atención de la diabetes tipo II.
13. The United Kingdom Prospective Diabetes Study Group: U.K. Prospective diabetes study.
14. Geller, a. i. et al. national estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. Jama Int. Med. 174, 678-686 (2014).
15. Krikorian, A., Ismail-Beigi, F. & Moghissi, E. S. Comparisons of different insulin infusion protocols: a review of recent literature. Curr. Opin. Clin. Nutr. Metab. Care 13, 198-204 (2010).
16. Umpierrez, G. E. et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 30, 2181-2186 (2007).
17. Feliciano Jhon. Mortalidad por diabetes mellitus en Colombia desde 2004-2010, Asociación Latinoamericana de Diabetes, ALAD N3 vol 4, 97-105 (2014).
18. Kitabchi, A. E., Umpierrez, G. E., Miles, J. M. & Fisher, J. N. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32, 1335-1343 (2009).
19. Centers for Disease Control and Prevention. Diabetes data & trends. [online] http://www.cdc.gov/nchs/fastats/inpatient-surgery.htm (2015).
20. Ox, C. S. et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 38, 1777-1803 (2015).
21. Cryer, P. E. Hypoglycemia-associated autonomic failure in diabetes: mal- adaptive, adaptive, or both? Diabetes 64, 2322-2323 (2015).
22. Geller, A. I. et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Int. Med. 174, 678-686 (2014).
23. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013;368:1613-1624.
24. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-268 29. Estacio RO, McFarling E, Big- gerstaff S, Jeffers BW, Johnson D, Schrier RW. Overt albuminuria predicts diabetic retinopathy in His- panics with NIDDM. Am J Kidney Dis 1998;31: 947-953.
25. Leske MC, Wu S-Y, Hennis A, et al.; Barbados Eye Study Group. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmology 2005;112:799-805.
26. Chew EY, Davis MD, Danis RP, et al.; Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology 2014; 121:2443-2451.
27. Freeman R. Not all neuropathy in diabetes is of diabetic etiology: differenial diagnosis of diabetic neuropathy. Curr Diab Rep 2009;9:423-431.

Authors must state that they reviewed, validated and approved the manuscript's publication.  Moreover, they must sign a model release that should be sent.  A copy may be reviewed here

Dimensions


PlumX


Downloads

Download data is not yet available.